BioXcel Therapeutics Inc
BTAI2.230USD
+0.860+62.77%
Horário de mercado （ET）Cotações atrasadas em 15 min
12.19MValor de mercado
PerdaP/L TTM
Mais detalhes de BioXcel Therapeutics Inc Empresa
BioXcel Therapeutics, Inc. is a biopharmaceutical company utilizing artificial intelligence to develop medicines in neuroscience. Its subsidiary, OnkosXcel Therapeutics, develops medicines in immuno-oncology. The Company’s most advanced neuroscience candidate, BXCL501, is an investigational, proprietary, orally dissolving film formulation of Dex in development for the treatment of agitation associated with psychiatric and neurological disorders. It is continuing to develop BXCL501 for the potential acute treatment of agitation associated with bipolar disorders or schizophrenia in the at-home setting and for the potential acute treatment of agitation (non-daily) associated with dementia due to probable Alzheimers disease in the at-home setting and in care facilities. Its most advanced immuno-oncology candidate, BXCL701, is an investigational oral innate immune activator for the treatment of aggressive forms of prostate cancer, pancreatic cancer, and other solid and liquid tumors.
Informações da empresa
Código da empresaBTAI
Nome da EmpresaBioXcel Therapeutics Inc
Data de listagemMar 08, 2018
CEODr. Vimal Mehta, Ph.D.
Número de funcionários37
Tipo de títulosOrdinary Share
Fim do ano fiscalMar 08
Endereço555 Long Wharf Dr
CidadeNEW HAVEN
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal06511-6107
Telefone12036438060
Sitehttps://www.bioxceltherapeutics.com/
Código da empresaBTAI
Data de listagemMar 08, 2018
CEODr. Vimal Mehta, Ph.D.
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Vimal Mehta, Ph.D.
Dr. Vimal Mehta, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
19.80K
+373.89%
Mr. David J. Mack
Mr. David J. Mack
Independent Director
Independent Director
18.62K
+10.00%
Dr. Michal Votruba, M.D., Ph.D.
Dr. Michal Votruba, M.D., Ph.D.
Independent Director
Independent Director
11.52K
--
Dr. Peter Mueller, Ph.D.
Dr. Peter Mueller, Ph.D.
Lead Independent Chairman of the Board
Lead Independent Chairman of the Board
7.49K
-42.90%
Mr. Javier Rodriguez
Mr. Javier Rodriguez
Senior Vice President, Chief Legal Officer, Corporate Secretary
Senior Vice President, Chief Legal Officer, Corporate Secretary
6.66K
+301.39%
Mr. Richard I. Steinhart
Mr. Richard I. Steinhart
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
6.44K
+346.98%
Mr. Erik Kopp
Mr. Erik Kopp
Investor Relations
Investor Relations
--
--
DR. Frank D. Yocca ,Ph.D.
DR. Frank D. Yocca ,Ph.D.
Executive Vice President, Chief Scientific Officer
Executive Vice President, Chief Scientific Officer
--
--
Dr. Rajiv Patni, M.D.
Dr. Rajiv Patni, M.D.
Independent Director
Independent Director
--
--
Ms. June Bray
Ms. June Bray
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Vimal Mehta, Ph.D.
Dr. Vimal Mehta, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
19.80K
+373.89%
Mr. David J. Mack
Mr. David J. Mack
Independent Director
Independent Director
18.62K
+10.00%
Dr. Michal Votruba, M.D., Ph.D.
Dr. Michal Votruba, M.D., Ph.D.
Independent Director
Independent Director
11.52K
--
Dr. Peter Mueller, Ph.D.
Dr. Peter Mueller, Ph.D.
Lead Independent Chairman of the Board
Lead Independent Chairman of the Board
7.49K
-42.90%
Mr. Javier Rodriguez
Mr. Javier Rodriguez
Senior Vice President, Chief Legal Officer, Corporate Secretary
Senior Vice President, Chief Legal Officer, Corporate Secretary
6.66K
+301.39%
Mr. Richard I. Steinhart
Mr. Richard I. Steinhart
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
6.44K
+346.98%
Detalhamento da receita
Sem dados
Sem dados
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: qui, 24 de jul
Atualizado em: qui, 24 de jul
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Bioxcel Corp
7.93%
Armistice Capital LLC
4.76%
Murchinson Ltd.
2.25%
UBS Financial Services, Inc.
1.68%
Goldman Sachs & Company, Inc.
0.41%
Other
82.97%
Investidores
Investidores
Proporção
Bioxcel Corp
7.93%
Armistice Capital LLC
4.76%
Murchinson Ltd.
2.25%
UBS Financial Services, Inc.
1.68%
Goldman Sachs & Company, Inc.
0.41%
Other
82.97%
Tipos de investidores
Investidores
Proporção
Corporation
7.93%
Hedge Fund
4.76%
Investment Advisor
2.76%
Investment Advisor/Hedge Fund
2.62%
Individual Investor
1.28%
Research Firm
0.89%
Other
79.75%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
225
1.20M
19.77%
-199.41K
2025Q1
248
1.19M
19.87%
-219.94K
2024Q4
260
1.00M
33.25%
-269.93K
2024Q3
269
724.21K
25.25%
-802.39K
2024Q2
282
1.14M
44.29%
-598.60K
2024Q1
282
1.17M
59.63%
-354.60K
2023Q4
282
1.17M
63.22%
-360.50K
2023Q3
290
1.23M
67.44%
-639.74K
2023Q2
289
1.71M
93.56%
-204.68K
2023Q1
297
1.69M
93.06%
-56.17K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Bioxcel Corp
480.34K
7.93%
-53.83K
-10.08%
Jun 06, 2024
Armistice Capital LLC
288.13K
4.76%
-24.20K
-7.75%
Mar 31, 2025
Murchinson Ltd.
136.08K
2.25%
+136.08K
--
Mar 31, 2025
UBS Financial Services, Inc.
101.78K
1.68%
+21.97K
+27.53%
Mar 31, 2025
Goldman Sachs & Company, Inc.
24.79K
0.41%
+24.79K
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
22.87K
0.38%
-508.00
-2.17%
Mar 31, 2025
Geode Capital Management, L.L.C.
22.06K
0.36%
+2.56K
+13.15%
Mar 31, 2025
Mehta (Vimal)
4.18K
0.07%
+382.00
+10.06%
Jun 15, 2025
Beacon Pointe Advisors LLC
18.84K
0.31%
+18.84K
--
Mar 31, 2025
The Vanguard Group, Inc.
18.82K
0.31%
+18.82K
--
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 2 de ago
Atualizado em: sáb, 2 de ago
Nome
Proporção
ProShares Hedge Replication ETF
0%
Schwab U.S. Small-Cap ETF
0%
iShares Neuroscience and Healthcare ETF
0%
ProShares UltraPro Russell2000
0%
Schwab U.S. Broad Market ETF
0%
iShares Micro-Cap ETF
0%
iShares Morningstar Small-Cap ETF
0%
Fidelity MSCI Health Care Index ETF
0%
Virtus LifeSci Biotech Clinical Trials ETF
0%
WisdomTree Artificial Intelligence and Innov Fund
0%
Ver Mais
ProShares Hedge Replication ETF
Proporção0%
Schwab U.S. Small-Cap ETF
Proporção0%
iShares Neuroscience and Healthcare ETF
Proporção0%
ProShares UltraPro Russell2000
Proporção0%
Schwab U.S. Broad Market ETF
Proporção0%
iShares Micro-Cap ETF
Proporção0%
iShares Morningstar Small-Cap ETF
Proporção0%
Fidelity MSCI Health Care Index ETF
Proporção0%
Virtus LifeSci Biotech Clinical Trials ETF
Proporção0%
WisdomTree Artificial Intelligence and Innov Fund
Proporção0%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Feb 06, 2025
Merger
16<1
Feb 06, 2025
Merger
16<1
Feb 06, 2025
Merger
16<1
Feb 06, 2025
Merger
16<1
Data
Tipo
Proporção
Feb 06, 2025
Merger
16<1
Feb 06, 2025
Merger
16<1
Feb 06, 2025
Merger
16<1
Feb 06, 2025
Merger
16<1
